Abstract #0721

Quantitative mDixon Fat Fraction can differentiate metastatic nodes from benign nodes in prostate cancer patients.

Mrishta Brizmohun Appayya¹, James O’Callaghan¹, Arash Latifoltojar¹, Edward W Johnston¹, Harbir S Sidhu¹, Abdulrhman Alnaim², Asim Afaq², Jamshed Bomanji², Alan Bainbridge³, and Shonit Punwani⁴

¹Centre of Medical Imaging, UCL, London, United Kingdom, ²Nuclear Medicine, UCLH, London, United Kingdom, ³Physics, UCL, London, United Kingdom, ⁴Centre for Medical Imaging, UCL, London, United Kingdom

Metastatic nodes in prostate cancer are associated with poor prognosis. Conventional MRI, relying on short-axis diameter (SAD) suffers from poor accuracy in identifying metastatic nodes. In this study, we compare fat fraction signal from MRI mDixon acquisitions (FF) with apparent diffusion coefficients of nodes and quantitative contrast-enhanced two-point mDixon T1 images (CE-mDixon), in discriminating between benign and metastatic nodes using 18F-Choline PET-CT as reference standard. We showed that FF and CE-mDixon discriminate benign from involved lymph nodes that are small in size unlike SAD or ADC of nodes; FF, not necessitating contrast agents, holds promise as a clinical tool.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.